Angiotensin 1/2 (2-7): High-Purity Peptide for Blood Pres...
Angiotensin 1/2 (2-7): High-Purity Peptide for Blood Pressure and RAS Research
Executive Summary: Angiotensin 1/2 (2-7) is a synthetic peptide fragment (sequence: ARG-VAL-TYR-ILE-HIS-PRO) derived from the enzymatic cleavage of angiotensin I and II, crucial for dissecting the renin-angiotensin system (RAS) in blood pressure and cardiovascular studies (Oliveira et al., 2025). It is validated by high-purity analytical methods (HPLC, MS, ≥99.80%) and shows robust solubility in water, ethanol, and DMSO under controlled laboratory conditions (APExBIO). Angiotensin 1/2 (2-7) modulates vasoconstriction, stimulates aldosterone release, and enhances sodium retention, making it a core tool for hypertension and cardiovascular disease research. Recent evidence highlights its role in modulating SARS-CoV-2 spike protein interactions with host receptors, expanding its utility to infectious disease models (Oliveira et al., 2025). The reagent is strictly intended for scientific research, not clinical or diagnostic use.
Biological Rationale
Angiotensin 1/2 (2-7) is a peptide fragment generated from the N-terminal region of angiotensin I and II by selective enzymatic cleavage in the RAS pathway (Oliveira et al., 2025). The RAS is a highly conserved hormone system that governs blood pressure, electrolyte balance, and vascular tone. Angiotensin peptides serve as substrates and effectors within this signaling cascade, exerting precise control over vasoconstriction and renal sodium handling (APExBIO). The sequence ARG-VAL-TYR-ILE-HIS-PRO (residues 2-7) defines the core bioactive domain for multiple downstream effects. Angiotensin 1/2 (2-7) is thus central to dissecting RAS signaling, hypertension, and the physiological response to cardiovascular stress.
Mechanism of Action of Angiotensin 1/2 (2-7)
Angiotensin 1/2 (2-7) is produced via renin-mediated cleavage of angiotensinogen to angiotensin I, followed by ACE action yielding various fragments (Oliveira et al., 2025). This fragment acts as a vasoconstrictor by promoting aldosterone release from the adrenal cortex. Aldosterone, in turn, enhances sodium reabsorption in the distal nephron, leading to increased blood volume and vascular resistance. The peptide also interfaces with G protein-coupled receptors (e.g., AT1R, AT2R) and can modulate additional signaling molecules such as reactive oxygen species and nitric oxide, depending on cellular context.
Recent data indicate that truncated angiotensin peptides, including Angiotensin 1/2 (2-7), can enhance binding of the SARS-CoV-2 spike protein to host cell receptors, notably AXL, potentially influencing viral pathogenesis (Oliveira et al., 2025).
Evidence & Benchmarks
- Angiotensin 1/2 (2-7) possesses a defined amino acid sequence (ARG-VAL-TYR-ILE-HIS-PRO) and a molecular weight of 783.92 Da (APExBIO).
- Peptide purity is validated at 99.80% by HPLC and mass spectrometry, ensuring batch-to-batch consistency (APExBIO).
- Solubility benchmarks: ≥46.6 mg/mL in water, ≥2.78 mg/mL in ethanol, and ≥78.4 mg/mL in DMSO at room temperature (APExBIO).
- Shortened angiotensin peptides (including (2-7)) increase SARS-CoV-2 spike protein binding to AXL by up to 2.7-fold in antibody-based assays (Oliveira et al., 2025).
- Angiotensin 1/2 (2-7) modulates aldosterone secretion and sodium retention, affecting blood pressure homeostasis (Oliveira et al., 2025).
- Storage at -20°C preserves peptide stability for >6 months (solid form), with solutions recommended for short-term use only (APExBIO).
Applications, Limits & Misconceptions
Angiotensin 1/2 (2-7) is a versatile research tool for:
- Modeling RAS signaling in hypertension and cardiovascular disease (related article – this article provides updated solubility and purity benchmarks for experimental troubleshooting).
- Dissecting aldosterone-mediated sodium handling in renal physiology.
- Elucidating peptide fragment effects on viral spike protein–receptor interactions in infectious disease models, especially SARS-CoV-2 (related article – here, we extend mechanistic insight to new receptor interactions not previously covered).
- Benchmarking peptide purity and solubility in workflow optimization (related article – this article adds updated data on peptide storage and stability in solution).
Common Pitfalls or Misconceptions
- Angiotensin 1/2 (2-7) is not suitable for direct clinical or diagnostic use; it is strictly for laboratory research (APExBIO).
- The peptide's effects are context-dependent and may not fully recapitulate the actions of full-length angiotensin I or II.
- Improper storage (above -20°C or repeated freeze-thaw cycles) rapidly degrades the peptide and reduces activity.
- Solubility in buffers may differ from manufacturer benchmarks if pH or ionic strength is not controlled.
- Data from recombinant or animal models may not translate directly to human pathophysiology without further validation.
Workflow Integration & Parameters
The Angiotensin 1/2 (2-7) reagent (SKU: A1050, APExBIO) is supplied as a lyophilized powder, facilitating accurate reconstitution. Recommended storage is at -20°C in a desiccated environment; working solutions should be prepared fresh and used within 1–2 weeks for optimal reproducibility. The peptide dissolves readily in water, DMSO, or ethanol at the specified concentrations. For cellular assays, titration across a range of 1 nM–10 µM is common, but users should consult literature or perform pilot dose-responses. Analytical verification (HPLC, MS) prior to use is best practice for critical experiments. APExBIO provides batch-specific certificates of analysis confirming purity, solubility, and identity.
Conclusion & Outlook
Angiotensin 1/2 (2-7) is a rigorously defined tool for modeling RAS signaling, blood pressure regulation, and viral receptor interactions in preclinical research. Its purity, stability, and robust solubility enable reproducible workflows for both cardiovascular and infectious disease studies. Future research avenues include detailed mapping of fragment-specific receptor binding and post-translational modifications influencing pathogenesis. For further details on this product, see the official APExBIO page: Angiotensin 1/2 (2-7).